Effect of etoperidone on the depletion of brain 5-hydroxytryptamine and catecholamines induced respectively by p-chloromethamphetamine and 6-hydroxydopamine in rats.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002997:Clomipramine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006892:Hydroxydopamines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008694:Methamphetamine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013997:Time Factors; D014196:Trazodone / Q000031:analogs & derivatives / Q000494:pharmacology*
D000928:Antidepressive Agents; D002395:Catecholamines; D006892:Hydroxydopamines; D010879:Piperazines; D012701:Serotonin; D008694:Methamphetamine; C013528:etoperidone; D002997:Clomipramine; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine; D014196:Trazodone